As the healthcare debate wages on, tea parties are top of mind.
The report that claims UnitedHealth Group is telling employees to participate in “tea parties,” is simply not true, according to a UnitedHealth e-mail.
UnitedHealth spokesman John Parker said the company doesn’t share third-party event listings, but only information about town halls sponsored by members of Congress.
“It’s beneficial for United from a business perspective to educate others about town halls sponsored by members of Congress early in the healthcare debate process,” says Georgette Pascale, president, Pascale Communications LLC, a healthcare public relations firm in Pittsburgh, Pa.
“They are being proactive about information and getting to the forefront of the debate on the future structure of healthcare delivery in the United States,” she says. “In the current environment, I feel that sometimes big insurers are painted as bad guys so with this approach, they are not being left out of the conversation; they are simply educating/disseminating public information in a timely manner.”
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More